Biotech stocks, which have risen 550% since the depths of the recession, are now prime targets of sh – HedgeChatter

Biotech stocks, which have risen 550% since the depths of the recession, are now prime targets of sh

25 Jun

Biotech stocks, which have risen 550% since the depths of the recession, are now prime targets of sh

ByHamilton Nolan biotech-stocks, bubble, financial, prime-targets, read-more-read-more, recession, short, since-the-depths, the-recession, watch, will-collapse Comments Off

Biotech stocks, which have risen 550% since the depths of the recession, are now prime targets of short sellers betting they will collapse in grand fashion. “Of any part of the market, this is the one with the most bubble-like characteristics, without question.”

Bubble Watch: Biotech Edition Bubble Watch: Biotech Edition Bubble Watch: Biotech Edition

The financial markets have been on the rise for the past six years. That can only mean that doom is … Read more Read more

See original:

Biotech stocks, which have risen 550% since the depths of the recession, are now prime targets of sh

See which stocks are being affected by Social Media

Author

Hamilton Nolan